ClinicalTrials.Veeva

Menu

Interval Training and Cardio-metabolic Health in Overweight/Obese Girls

A

Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose

Status

Enrolling

Conditions

Exercise Overtraining
Enjoyment
Cardiometabolic Syndrome
Obesity

Treatments

Other: MIIT
Other: MIIT + HIIT
Other: Control group

Study type

Interventional

Funder types

Other

Identifiers

NCT06538714
CERB 16/2024

Details and patient eligibility

About

The main purpose of this study is to compare the impact of 12-week moderate-intensity interval training (MIIT) versus combined MIIT with high-intensity interval training (HIIT) on physical fitness, cardio metabolic, lipidomic, hematological and psychological characteristics in young overweight/obese girls.

Enrollment

45 estimated patients

Sex

Female

Ages

12 to 15 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female gender,
  • Overweight or obese according to the BMI classification,
  • Age, 12 to 15 years,
  • Personal or parental/guardian written consent

Exclusion criteria

  • Severe infectious or inflammatory diseases,
  • Irregular menstrual cycles
  • Participation in organized exercise training in the last 6 months or additional physical -
  • recreational activities, except physical education classes.
  • Using medications, hormone therapy or dietary supplements

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

45 participants in 3 patient groups, including a placebo group

MIIT
Experimental group
Description:
12-week supervised exercise program consisting of moderate -intensity interval training (MIIT)
Treatment:
Other: MIIT
MIIT+ HIIT
Active Comparator group
Description:
12-week supervised exercise program consisting of moderate-intensity interval training (MIIT) (6-week) and high-intensity interval training (HIIT) (6-week).
Treatment:
Other: MIIT + HIIT
Control group No training
Placebo Comparator group
Treatment:
Other: Control group

Trial contacts and locations

2

Loading...

Central trial contact

Amani Kallel, PhD; Moncef Feki, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems